Stockwinners Market Radar for November 14, 2017 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

19:07 EDT AstraZeneca's FASENRA receives FDA approval - AstraZeneca announced that the US Food and Drug Administration has approved FASENRA for the add-on maintenance treatment of patients with severe asthma aged 12 years and older, and with an eosinophilic phenotype. FASENRA is not approved for the treatment of other eosinophilic conditions or relief of acute bronchospasm or status asthmaticus. Pascal Soriot, Chief Executive Officer of AstraZeneca, said: "We're excited to offer FASENRA as a new precision biologic to help improve the lives of severe asthma patients whose disease is driven by eosinophilic inflammation. This is the first approval from our respiratory biologics portfolio and the latest in a series of significant milestones for our company as we deliver on our pipeline-driven transformation."

18:25 EDT Mitek Systems exec Gray sells 12,211 common shares - In a regulatory filing, Mitek Systems executive Jason Gray disclosed the sale of 12,211 common shares of the company at a price of $9.1303 per share.

18:11 EDT Alaska Air to end flights to Havana, Cuba - Alaska Airlines announced that it will end a daily flight between Los Angeles and Havana, Cuba. The last flight is planned for Jan. 22. The airline will redeploy aircraft used to serve Havana to markets with higher demand.

17:48 EDT Pershing Square exits Nomad Foods position, reduces Restaurant Brands stake - Bill Ackman's Pershing Square Capital Management disclosed in an SEC filing its holdings as of September 30. Pershing Square exited one position during the quarter, Nomad Foods (NHL). Pershing Square increased its stake in one holding, ADP (ADP). Pershing Square reduced its stake in two holdings, including by size of previous position, Restaurant Brands (QSR) and Mondelez (MDLZ). Pershing Square's top holdings as of September 30, in order of size, were Restaurant Brands, ADP, Chipotle Mexican Grill (CMG), Mondelez, and Howard Hughes Corp (HHC).

17:38 EDT Netlist prevails in patent trial with SanDisk, Smart Modular - Netlist announced the U.S. Court of Appeals for the Federal Circuit affirmed earlier decisions from the U.S. Patent Trial and Appeal Board confirming the validity of certain claims of Netlist's U.S. Pat. Nos. 8,001,434 (434 Patent) and 8,359,501 (501 Patent). Netlist's '434 and '501 patents cover self-test technologies widely used in LRDIMMs, SSDs, and Storage Class Memory. Netlist has asserted these patents as part of a seven-patent lawsuit against SanDisk and Diablo Technologies. SanDisk and Smart Modular filed a total of six petitions for Inter Partes Review challenging the validity of these two patents, which have now been resolved in Netlist's favor by the Federal Circuit. Netlist has also asserted the '434 and '501 patents in the U.S. International Trade Commission against SK hynix's LRDIMM and RDIMM enterprise memory products. The ITC is expected to issue a final determination in its investigation of SK hynix by March 14, 2018. Any appeals from this final determination will also be heard by the Federal Circuit.

17:30 EDT Netlist announces ITC ruling on its memory patents - Netlist, Inc announced that Administrative Law Judge Bullock of the United States International Trade Commission, issued a Notice of Initial Determination in its investigation of SK hynix RDIMM and LRDIMM enterprise memory products. According to the Notice, ALJ Bullock determined that no violation of section 337 of the Tariff Act has been found with respect to Netlist's patents in Certain Memory Modules and Components Thereof, and Products Containing Same, Investigation No. 337-TA-1023. The Notice includes only a brief summary of the ID's conclusions, so no further details on the substance of the decision are available at this time. The parties and their counsel have not yet received the full ID, which is subject to confidentiality restrictions. Netlist anticipates its counsel will receive this document within the next few days. Netlist will determine at that time whether further comment on the decision is appropriate. A public version of the ID will be available within 30 days. The ID is now subject to review by the Commissioners at the ITC. Netlist intends to petition for review of any findings in the ID it believes are incorrect. The Commission will then decide whether to review portions of, or the entire ID. Once the issues under review have been briefed, the Commission may affirm, set aside, or modify the portions of the ID under review. These conclusions will be contained in a Final Determination which is currently scheduled to be issued by the Commission by March 14, 2018.

17:24 EDT On The Fly: After Hours Movers - UP AFTER EARNINGS: CarGurus (CARG), up 9.8%... Westport (WPRT), up 8.7%... Synacor (SYNC), up 8.7%... Beazer Homes (BZH), up 4.4%. ALSO HIGHER: Lam Research (LRCX), up 2.1% after it announced a $2B share buyback plan and raised its quarterly dividend 11%... HP Enterprise (HPE), up 1.4% Greenlight Capital disclosed that it increased its stake in the company... Synchrony Financial (SYF), up 1.3% after Berkshire Hathaway raised its stake in the company. DOWN AFTER EARNINGS: A-Mark Precious Metals (AMRK), down 12.6%... Macom (MTSI), down 7.7%... NovaBay (NBY), down 5.6%. ALSO LOWER: Achillion (ACHN), down 8.4% after it filed to sell 18.4M shares of common stock for holders... Genpact (G), down 2.8% after it filed to sell 10M shares of common stock for holders.

17:16 EDT Scorpio Bulkers announces purchase of 350K shares by Scorpio Services - Scorpio Bulkers announced that Scorpio Services Holding Limited has purchased 350,000 common shares of the company at an average price of $7.19 per share in the open market. SSH owns a total of 13,977,513 common shares or approximately 18.5% of the company.

17:08 EDT BAE Systems awarded $139.8M U.S. Navy contract - BAE Systems Norfolk Ship Repair, Norfolk, Virginia, is being awarded a $139,818,901 firm-fixed-price contract for the execution of USS Tortuga fiscal 2018 modernization period Chief of Naval Operations availability. This availability will include a combination of maintenance, modernization, and repair of USS Tortuga. This contract includes options which, if exercised, would bring the cumulative value of this contract to $183,794,039. Work will be performed in Norfolk, Virginia, and is expected to be completed by May 2019.

17:00 EDT Lam Research announces $2B share repurchase plan, raises dividend 11%

16:57 EDT ITC to investigate Apple over claims of patent infringement - The U.S. International Trade Commission has voted to institute an investigation of certain personal computers, mobile devices, digital media players, and microconsoles. The products at issue in the investigation are certain Apple Mac computers, iPhones, iPads, iPods, and Apple TVs. The investigation is based on a complaint filed by Aqua Connect, Inc., and Strategic Technology Partners, LLC, of Orange, CA, on October 10, 2017. The complaint alleges violations of section 337 of the Tariff Act of 1930 in the importation into the United States and sale of certain personal computers, mobile devices, digital media players, and microconsoles that infringe patents asserted by the complainants. The complainants request that the USITC issue a temporary exclusion order and a temporary cease and desist order based on a motion for temporary relief, and that the USITC ultimately issue a limited exclusion order and a cease and desist order. The USITC has identified Apple Inc. of Cupertino, CA, as the respondent in this investigation. Reference Link

16:53 EDT North Tide Capital to sell remaining shares of Tivity Health - Tivity Health announced that North Tide Capital, which currently holds 630,000 shares of Tivity Health, representing 1.6% of the total outstanding common shares of the Company, has entered into a Rule 10b5-1 trading plan pursuant to which the firm intends to sell its remaining shares in Tivity Health by year-end 2017, as part of the wind down of its funds. North Tide's Founder and Portfolio Manager Conan Laughlin, who has served on the Tivity Health Board of Directors since 2014, will continue to serve on the Board through his current term.

16:46 EDT Amarin announces real world Hypertriglyceridemia data analysis - Amarin Corporation announced data analysis orally presented today at the American Heart Association 2017 Scientific Sessions in Anaheim, California. The oral presentation used real world evidence as a basis for the analysis. This analysis of RWE is separate from and independent of the RWE analysis referenced in Amarin's press release on November 12, 2017. The study analyzed data from the Southern California and Northwest regions of Kaiser Permanente, one of America's leading health care providers and not-for-profit health plans. The patients selected had a diagnosis of atherosclerotic cardiovascular disease and had statin-controlled LDL cholesterol. The study concluded that during the study period, despite statin-controlled LDL-C levels, ASCVD events were greater among patients with ASCVD and high vs. normal triglyceride levels.

16:39 EDT A-Mark Precious Metals down 8% to $14.00 after Q1 earnings miss estimates

16:33 EDT Devon Energy announces 5,100Boe per day well is online - Devon Energy announced it has brought online a high-rate Lower Meramec oil well offsetting its Coyote development in the over-pressured oil window of the STACK play. The Faith Marie 1-H resides directly adjacent to the company's Coyote development project in Blaine County and achieved a peak 24-hour rate of 5,100Boe per day. The projected 30-day rate for this 9,000-foot lateral well is 4,600 Boe per day. Oil productivity from the Faith Marie is the highest of any STACK well to date targeting the Lower Meramec interval. Well productivity at Faith Marie was enhanced by a new completion design that improved stimulated rock volume through the systematic cycling of pressure and fluid rates. The new completion design also lowered well costs at Faith Marie to $9M. This improvement compared to legacy wells in the area was driven by the use of a higher viscosity slickwater fluid system, increases in frac stage length and other proprietary modifications. In the Q4, the company expects to bring online approximately 25 wells in the STACK play that will benefit from the improved completion design. This new well activity will primarily reside in the over-pressured oil window of the play and is expected to increase net production in the STACK to more than 120,000 Boe per day by year end.

16:27 EDT Mid-Con Energy to sell assets within its Southern Oklahoma core area for $25M - Mid-Con Energy announced that it had entered into a definitive agreement to sell oil and natural gas assets within its Southern Oklahoma core area to an unaffiliated buyer for $25.0M, subject to customary post-closing adjustments. The effective date of the divestiture is October 1 and closing is expected to occur on or before November 30. Proceeds from the sale will be used to reduce borrowings outstanding under the Partnership's revolving credit facility. The Partnership will divest the entirety of its Southern Oklahoma core area, which as of December 31, 2016, was comprised of 89 gross oil and natural gas producing wells, 55 gross injection wells, 5 gross water supply wells, and 36 gross inactive wells. Estimated net total proved reserves at year end 2016 were 2.7MMBoe and average net production during the Q3 was approximately 540 Boe/d.

16:17 EDT Future FinTech to delay filing of quarterly report on Form 10-Q - Future FinTech announced that it will be delaying the filing of its Quarterly Report on Form 10-Q for the quarter ended September 30, 2017. The company has filed an extension with the SEC in accordance with Rules 12b-25(b) and 12b-25(c) for the Form 10-Q and anticipates filing the Form 10-Q on or before the fifth calendar day following the prescribed due date.

16:13 EDT Macom drops 13% after Q1 outlook misses estimates

16:08 EDT Air Products extends term of CEO Seifi Ghasemi through September 30, 2022 - Air Products Board of Directors announced that it has entered an amended and restated employment agreement with Air Products' chairman, president and CEO Seifi Ghasemi. The new agreement extends Ghasemi's term through September 30, 2022. Ghasemi was named chairman, president and chief executive officer in 2014. He has led the company through a transformation over the past three years to industry leading safety and financial performance.

16:03 EDT Acceleron reports 'positive' preclinical results in sotatercept trial - Acceleron Pharma announced new preclinical results with sotatercept in pulmonary arterial hypertension during an oral presentation at the American Heart Association 2017 Scientific Sessions in Anaheim, California. "We are extremely encouraged by these positive preclinical results, which support our mechanistic approach for sotatercept and its potential to be a first-in-class disease-modifying therapy for patients with pulmonary arterial hypertension. We look forward to initiating a Phase 2 trial with sotatercept in PAH during the first half of 2018," said Ravi Kumar, Chief Scientific Officer for Acceleron. The oral presentation by Paul Yu, M.D., Ph.D., Associate Professor of Medicine, Brigham and Women's Hospital, entitled "ACTRIIA-Fc rebalances BMP and activin/TGFbeta signaling to attenuate experimental pulmonary hypertension," provided data from three animal models of PAH demonstrating potent effects of sotatercept on many aspects of vascular and cardiac disease. In animals treated early in disease progression, sotatercept blocked the development of pulmonary vascular remodeling and right heart failure, and prevented the increase in pulmonary arterial pressure. For animals treated after established disease, sotatercept achieved a marked reduction in intimal-medial thickness of pulmonary arterioles relative to untreated animals, decreased vessel muscularization, improved pulmonary arterial pressures and decreased indicators of right heart failure. "The sotatercept preclinical results show remarkable biological activity, particularly on the pulmonary vasculature, across multiple, well-established animal models of PAH," said Dr. Yu. "These results are very exciting, and further establish the importance of signaling by the TGF-beta superfamily as a target for therapies to treat PAH."

16:02 EDT Neovasc reports Q3 EPS (6c), consensus (7c) - Reports Q3 revenue $1.37M, consensus $1.8M.

15:52 EDT DryShips moves higher after Apollo Management reports stake - Shares of DryShips rose after Apollo Management disclosed that it held a stake of about 1.24M shares in the company as of September 30.

14:39 EDT Avenue Capital Management II reports 13.9% passive stake in Midstates Petroleum

14:12 EDT Envision rises amid report of private equity interest - Shares of Envision Healthcare (EVHC) are on the rise following a report by Bloomberg claiming the company has attracted buyout interest from private equity investors. The hospital based physician group, which activist Starboard Value has targeted, had previously announced that it was exploring options to enhance shareholder value. Meanwhile, Baird analyst Whit Mayo told investors that Envision could be worth in the area of $40 per share in a leveraged buyout, which is an estimated value that his peer at Keybanc also sees as possible. PRIVATE EQUITY INTEREST: According to a report by Bloomberg, Envision has attracted buyout interest from firms including Carlyle Group (CG) and Onex Corp. The two are among companies that may bid for Envision alone or as part of a group, the report added. The health-services provider has been under pressure from activist investor Starboard Value, who revealed a stake in Envision in October and recommended the company as an attractive takeover target, Bloomberg noted. LBO 'DOABLE': In a research note to investors published prior to the release of Bloomberg's report, Baird's Mayo noted that he would guess that about three to four hedge funds now collectively own about 20% of Envision Healthcare, with "potentially more in the shadows," and that a leveraged buyout is "very doable" if one believes there is an investment case for industry volumes. If there is a case seen for structural changes in volumes, cash collections and/or physician rate, Mayo sees the potential for "very acceptable returns" on a theoretical leveraged buyout in the $40 per share area, he contended. Mayo pointed out that he thinks the upside risk of a leveraged buyout is being "underappreciated," and reiterated an Outperform rating and $35 price target on the shares. Meanwhile, KeyBanc analyst Jason Gurda told investors in a research note of his own that he also believes a private equity buyer could reasonably bid "in the low $40s" for Envision in a leveraged buyout. The analyst noted that he was not surprised to hear of reports that there is private equity interest in the company as in the past there has been a considerable level of private equity investment in both of Envision's business segments - physician services and ambulatory surgical centers. Gurda reiterated an Overweight rating on the stock, while raising his price target on the shares to $40 from $37. PRICE ACTION: In afternoon trading, shares of Envision have jumped about 7% to $27.66. Year-to-date, however, the stock is still down over 56%.

13:42 EDT Brown Advisory reports 5.05% passive stake in Core-Mark

13:01 EDT Roche receives FDA approval for VENTANA MMR IHC panel - Roche announced US Food & Drug Administration clearance of the VENTANA MMR IHC Panel, which provides clinicians with a comprehensive group of immunohistochemistry tests for patients diagnosed with colorectal cancer. The tests detect certain proteins associated with a DNA repair mechanism called mismatch repair, and aid in differentiating between sporadic colorectal cancer and probable Lynch syndrome, a hereditary form of colorectal cancer. About 3% of colorectal cancers are associated with Lynch syndrome. The panel of five assays includes four that target MMR proteins MLH1, MSH2, MSH6 and PMS2, as well as the VENTANA BRAF V600E assay. This is the first FDA clearance of an IHC panel of this type. "The VENTANA MMR IHC Panel provides clinicians with an additional tool to perform universal tumor screening for probable Lynch syndrome as recommended by medical guidelines," said Ann Costello, Head of Roche Tissue Diagnostics. "The FDA clearance is a major milestone because this testing impacts not just the patient, but family members who may benefit from further genetic testing and advanced monitoring to detect colorectal cancer at its earlier stages, when it is more treatable."

12:37 EDT Envision Healthcare trading resumes

12:32 EDT Envision Healthcare trading halted, volatility trading pause

12:16 EDT JANA Partners takes stake in Jack in the Box, exits Cognizant position - JANA Partners disclosed in an SEC filing its holdings as of September 30. JANA Partners' nine new buys during the third quarter included, by size of position, Jack in the Box (JACK), UnitedHealth (UNH), Axalta Coating Systems (AXTA), Oracle (ORCL), and DR Horton (DHI). JANA Partners exited fourteen positions during the quarter, including by size of previous position, Cognizant Technology Solutions (CTSH), Hewlett Packard Enterprise (HPE), Sherwin Williams (SHW), Blackhawk Network Holdings (HAWK), and CDK Global (CDK). JANA Partners increased its stake in nine holdings, including by size of previous position, EQT Corp (EQT), Zimmer Biomet (ZBH), DXC Technology (CSC), Zayo Group (ZAYO), and Molina Healthcare (MOH). JANA Partners reduced its stake in twelve holdings, including by size of previous position, NuVasive (NUVA), Tiffany & CO (TIF), Pandora Media (P), Liberty Broadband (LBRDK), and Select Medical (SEM). JANA Partners' top holdings as of September 30, in order of size, were EQT Corp, Zimmer Biomet, Tiffany, Liberty Broadband, and HD Supply Holdings (HDS).

11:58 EDT Jack in the Box rises after Jana Partners discloses stake - Jana Partners' 13-F filing shows that the fund held about 1.317M shares of Jack in the Box as of September 30. Jack in the Box shares have jumped 6% following the filing.

11:34 EDT DBV announces publication of 'positive' Viaskin Peanut study - DBV Technologies announced that detailed results from the Vipes Phase IIb trial and the Olfus-Vipes extension study of Viaskin Peanut in peanut-allergic patients were published in the Journal of the American Medical Association. After 12 months, treatment with Viaskin Peanut resulted in a statistically significant response rate compared to placebo, which was followed by an increase in the observed treatment effect during the extension study, DBV says in a statement. Vipes was a 12-month dose-ranging trial designed to assess the efficacy and safety of Viaskin Peanut in 221 peanut-allergic patients six to 55 years of age. In the study, the primary efficacy endpoint, which was defined as the percentage of treatment responders for each active treatment group compared to placebo, was met with the 250 mcg dose of Viaskin Peanut. "Epicutaneous immunotherapy represents a new paradigm for how we can potentially treat peanut and other food allergies in a safe and effective way," said Dr. Hugh Sampson, Chief Scientific Officer of DBV Technologies, the Kurt Hirschhorn Professor of Pediatrics at the Icahn School of Medicine at Mount Sinai, and the lead author of this manuscript. "This first-ever publication of a large clinical trial of epicutaneous immunotherapy is a significant milestone, highlighting the potential for this new class of immunotherapy. With our ongoing comprehensive Phase III program in peanut-allergic children, we continue to expand our understanding of the long-term benefits of Viaskin Peanut."

11:04 EDT Blackhawk announces expanded gift card partnership with eBay - Blackhawk Network (HAWK) announced that it has expanded its longtime partnership with eBay (EBAY) to provide the online marketplace with end-to-end business-to-business gift card services. Through the new program, businesses can order eBay gift cards to reward or incentivize customers through loyalty, acquisition, retention or promotional programs.

10:46 EDT Omega Advisors takes stakes in Aetna, Expedia, exits Allergan position - Leon Cooperman's Omega Advisors disclosed in an SEC filing its holdings as of September 30. Omega's 21 new buys during the third quarter included, by size of position, Aetna (AET), Expedia (EXPE), Adobe (ADBE), A Schulman (SHLM), and DXC Technology (CSC). Omega exited 18 positions during the quarter, including by size of previous position, Allergan (AGN), Arris (ARRS), OneMain Holdings (OMF), L Brands (LB), and Gardner Denver Holdings (GDI). Omega increased its stake in 25 holdings, including by size of previous position, AMC Networks (AMCX), Trinity Industries (TRN), MaxLinear (MXL), WPX Energy (WPX) and Shire (SHPG). Omega reduced its stake in six holdings, including by size of previous position, AIG (AIG), MGM Resorts (MGM), Ellington Financial (EFC), Navient (NAVI), and Gigamon (GIMO). Omega's top holdings as of September 30, in order of size, were First Data (FDC), Alphabet (GOOGL), AerCap (AER), United Continental (UAL), and Shire.

10:31 EDT Ecopetrol 'stresses' Bermuda not on list of countries considered tax havens - Ecopetrol S.A issued the following statement on the "Paradise Papers" article: "In 2006, after completing the relevant analysis and with the necessary corporate authorizations, Ecopetrol S.A. organized the company Black Gold RE, domiciled in Bermuda, the corporate purpose of which was to support and foster the risk financing strategy of Ecopetrol and its subsidiaries and affiliates, in order to determine the optimal balance between retaining and transferring risks at any point in time. As a result, Black Gold RE has engaged in efficient yet extensive risk financing by accessing the international reinsurance market directly, which in turn allows it to mitigate the capacity and coverage restrictions that exist in the local insurance markets, negotiate better insurance premium rates, monitor insurance brokerage costs, increase its retention capacity to efficiently address rate changes in the insurance market, and consolidate and concentrate the financial and administrative operations of the GE Corporate Insurance Program, etc. It is important to stress that Bermuda is not included on the list of countries considered tax havens, pursuant to Colombian Ministry of Finance and Public Credit Decrees 1966 and 2095 of October 7 and 21, 2014. For accounting purposes, Ecopetrol fully consolidates the earnings generated by this subsidiary in its financial statements, which are audited by E&Y, the Group companies' current external auditor, and in the other periodic reports, including the quarterly report, published as relevant information in Colombia, through the official page of the Financial Superintendence of Colombia, and the 20F that must be presented to the Securities Exchange Commission of the United States of America."

10:02 EDT Takeda receives positive CHMP opinion for Adcetris for CD30-positive CTCL - Takeda Pharmaceutical announced that the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for the extension of the marketing authorization of ADCETRIS and recommended its approval for the treatment of adult patients with CD30-positive cutaneous T-cell lymphoma after at least one prior systemic therapy. ADCETRIS is an antibody-drug conjugate directed at CD30 which is expressed on skin lesions in approximately 50% of patients with CTCL. ADCETRIS is currently not approved for the treatment of CTCL. The CHMP positive opinion for ADCETRIS will now be reviewed by the European Commission, which has the authority to approve medicines for use in the 28 countries of the European Union, Norway, Liechtenstein and Iceland. The positive CHMP opinion is based on the results of the randomized, open-label Phase 3 ALCANZA study designed to evaluate single-agent ADCETRIS versus a control arm of investigator's choice of standard of care therapies in patients with CD30-positive CTCL. The trial achieved its primary endpoint and the ADCETRIS treatment arm demonstrated a highly statistically significant improvement in the overall response rate lasting at least four months versus the control arm as assessed by an independent review facility.

09:56 EDT Home Depot says does not see slowdown in housing from 2018-2020

09:50 EDT Liberty Expedia Holdings (Series B) trading resumes

09:45 EDT Liberty Expedia Holdings (Series B) trading halted, volatility trading pause

09:38 EDT General Electric CEO says 'very clear' yesterday on direction of company - Flannery said he is "not surprised" in the reaction in GE shares given the "disappointing news" the company delivered, but he is "very confident" in the direction the company is headed. General Electric CEO John Flannery is being interviewed on CNBC following the company's investor update meeting yesterday.

09:35 EDT Madison Square Garden intends to sell New York Liberty - Madison Square Garden announced that it intends to sell its original WNBA franchise, the New York Liberty. MSG is committed to identifying new ownership that will continue to grow the team, and is actively seeking a buyer to take over immediate operations of the franchise.

09:32 EDT GameStop CEO, Raines seeking medical treatment for previously disclosed issue - GameStop announced that its CEO, J. Paul Raines, has had a reoccurrence of his previously disclosed medical issue and is seeking treatment. In light of these developments, the board of the company has appointed the company's Executive Chairman, Daniel DeMatteo, as the company's interim CEO. DeMatteo, one of the company's co-founders, will continue to serve as Executive Chairman and director. In the past, DeMatteo has served as the company's CEO and in a variety of board and executive roles since November 1996.

09:30 EDT Home Depot says large ticket growth continues due to Pro business - Says "pleased" with online growth.

09:28 EDT Sikorsky's S-92 helicopter approved to operate in Mexico - Mexico's Directorate General of Civil Aeronautics, or DGAC, approved the Offshore and Utility Type Certificate for the Sikorsky S-92 helicopter. The certificate enables the operation of S-92 helicopters in Mexico, in all production configurations including offshore oil and gas transportation, search and rescue, as well as regional airline passenger service and VIP transportation. DGAC signed the certificate November 6, capping an intensive three-year effort to introduce the S-92 helicopter manufactured by Sikorsky, a Lockheed Martin Company, to Mexico.

09:26 EDT Lockheed Martin's S-92 helicopter approved in Mexico - Mexico's Directorate General of Civil Aeronautics, or DGAC, approved the Offshore and Utility Type Certificate for the Sikorsky S-92 helicopter. The certificate enables the operation of S-92 helicopters in Mexico, in all production configurations including offshore oil and gas transportation, search and rescue, as well as regional airline passenger service and VIP transportation. DGAC signed the certificate November 6, capping an intensive three-year effort to introduce the S-92 helicopter manufactured by Sikorsky, a Lockheed Martin Company, to Mexico.

09:22 EDT Starwood Waypoint shareholders approve merger with Invitation Homes - Starwood Waypoint Homes (SFR) announced that, at a special meeting held earlier, its shareholders approved the company's merger with and into a subsidiary of Invitation Homes Inc. (INVH) in a stock-for-stock transaction pursuant to the previously announced Agreement and Plan of Merger, dated August 9. Overall, the two companies have invested nearly $2B, an average of approximately $22,000 per home, in renovations and maintenance, improving resident experience and driving economic growth and job creation in local communities. The combined company will own and manage a portfolio of approximately 82,000 single-family homes. While Invitation Homes is expected to be the largest single-family rental company in the U.S. upon the closing of the Merger, its portfolio will represent less than 0.1% of the more than 90M single-family homes in the U.S. and just 0.5% of the nearly 16M single-family homes for rent in the U.S.The Merger is expected to close on or about November 16, subject to customary closing conditions. As a result of the Merger, each Starwood Waypoint Homes common share will be converted into 1.6140 shares of Invitation Homes common stock. Invitation Homes' common stock will continue to trade on the New York Stock Exchange under its existing ticker symbol.

09:21 EDT Boingo sees long-term revenue growth twice rate of growth of Wi-Fi providers - In slides for its analyst day meeting, Boingo Wireless said it sees long-term revenue growth of 2x the rate of growth vs. Wi-Fi Service Providers and 2x the rate of growth vs. Tower Companies. Long-term, the company sees double the EBITDA margin vs. Wi-Fi Service Providers and "lower, but much faster growing" EBITDA than Tower Companies. The company added it sees itself positioned in the "early innings of long-term investment cycle" and that 5G and Convergence create a "huge opportunity."

09:19 EDT Home Depot says sees FY17 gross margin down 12 bps - Sees FY17 tax rate 36.3%.

09:15 EDT Home Depot says 45% of Q3 online orders picked up in store

09:08 EDT Lockheed Martin awarded $44.1M contract by U.S. Air Force - Lockheed Martin received a $44.1M contract from the U.S. Air Force to produce Intelligent Test Instrumentation Kits, or iTIK, to be used on Joint Air-to-Surface Standoff Missile, or JASSM, flight tests for telemetry and flight termination purposes. This contract for iTIKs provides benefits across multiple missile programs. These upgraded iTIKs eliminate obsolete parts from previous generation test kits and provide a new product that can be used on several different missiles.

09:07 EDT Sorrento: Scilex Pharmaceuticals files European MAA for ZTlido - Sorrento Therapeutics announced that Scilex Pharmaceuticals, a majority-owned subsidiary of Sorrento, filed the European Marketing Authorization Application for its lead product candidate, ZTlido, through a hybrid regulatory pathway with the Medicines and Healthcare products Regulatory Agency in the United Kingdom. The UK will be the reference member state, or lead review agency, with corresponding filings in multiple other countries including Germany, France, Spain, Italy and Ireland. The review time for the MAA is 210 days with clock stops for information requests from agencies. Scilex expects to have a decision in the 4th quarter of 2018. The company is currently evaluating commercial options and partnerships for the EU, with a potential commercial launch date for Europe in 2019. Scilex currently has a new drug application under review with the FDA in the US for ZTlido.

09:05 EDT Purple Innovation appoints Mark Watkins as CFO - Purple Innovation announced that Mark Watkins has been named CFO, effective immediately. The announcement follows Purple's announcement on November 2 of a definitive merger agreement with Global Partner Acquisition. Watkins most recently served as the CFO of wood pellet grill pioneer, Traeger Pellet Grills, a post he held from March 2015 through October 2017. At Traeger, Watkins was responsible for the company's overall financial strategy through a period of rapid growth and expansion. Previously, Watkins held various positions of increasing responsibility at Nu Skin Enterprises, including Vice President of Sales Operations and Vice President of Finance.

09:02 EDT Wells Fargo will no longer charge overdraft fees for transactions $5 or under - Wells Fargo announced that it will no longer charge overdraft fees for any transaction of $5 or less, further helping customers avoid unexpected fees when their account balances are low. This new per-transaction threshold complements the bank's existing policy of not charging an overdraft fee if a customer's available balance and ending account balance is overdrawn by $5 or less and no items are returned for non-sufficient funds at the end of nightly processing. It is intended to help customers avoid additional overdraft fees for small transactions conducted after an account is initially overdrawn.

09:02 EDT Wells Fargo introduces Overdraft Rewind to help customers avoid fees - Wells Fargo & Company announced that it has introduced a new feature that will automatically "rewind" overdrafts that are assessed on customers' accounts at a vulnerable time -- specifically the day before their payday direct deposit is received, when their account balances may be low. With the new "Overdraft Rewind" feature, the bank will not charge overdraft or insufficient funds fees if a covering direct deposit is received the morning after their account is overdrawn. Customers do not need to take any action to receive the new benefit, automatically providing a better banking experience for millions of customers nationwide.

08:57 EDT Beneficial Bancorp announces formation of Neumann Finance - Beneficial Bank announced the formation of Neumann Finance - a new equipment leasing firm within Beneficial Bank, named after the bank's pioneering founder, John Neumann. The new strategic partnership will focus on providing financing products and services to businesses nationwide. The partnership between Beneficial Bank and Neumann Finance brings together two established leadership teams, building a network aimed at helping businesses find the best equipment financing options and services. Neumann Finance will target various equipment categories including technology, software, office, medical and other areas.

08:48 EDT Bank of America COO: Capital markets activity 'seems pretty robust' in Q4

08:38 EDT TJX maintains high end of FY EPS view

08:36 EDT TJX CEO: Hurricanes had negative impact during the quarter - ERnie Herrman, CEO and presidident of TJX, said "Certainly, the hurricanes had a negative impact during the quarter. Our greatest concern is the well-being of our Associates, their families, our customers and everyone affected by these natural disasters, and our hearts go out to the people who have been impacted. Additionally, we believe that warmer temperatures in the U.S. during the quarter dampened demand for apparel at our Marmaxx division. While sales were not as strong as we would have liked, we were pleased that sales trends at Marmaxx improved as the weather turned more seasonable. Further, customer traffic, or transactions, were strong and up at every major division. Importantly, our consolidated merchandise margin increased, which we believe speaks to the flexibility of our off-price business model. Overall, our organization sharply executed our off-price fundamentals of opportunistic buying, lean inventory discipline, and being strategic and targeted in the flow of merchandise to our stores, which helped drive margins. Looking ahead, the fourth quarter is off to a strong start and we see numerous opportunities for the holiday selling season across our retail banners. We have excellent inventory liquidity to capitalize on the plentiful opportunities we are seeing for quality, branded merchandise in the marketplace. We will be offering consumers eclectic gift selections from around the world, at compelling, off-price values, and shipping fresh assortments to our stores and online throughout December and beyond. We have many initiatives underway to drive sales and traffic and are excited about our marketing campaigns. We are confident that we will achieve our goals for 2017 and as always, we will strive to surpass them. We have enormous confidence in the continued, successful growth of TJX!"

08:33 EDT WellCare to offer enhanced Medicare Advantage Plan benefits in 2018 - WellCare Health Plans will offer a variety of Medicare Advantage health plans in 2018 that provide more benefits and services than Original Medicare. WellCare's plans emphasize preventive health measures and are specifically designed to meet the needs of cost-conscious older adults and dual-eligible beneficiaries seeking to get and stay healthy.

08:33 EDT Dick's Sporting appoints Paul Gaffney as Chief Technology Officer - DICK'S Sporting Goods (DKS) announced Paul Gaffney has been named Chief Technology Officer, effective November 20. In this role, Gaffney will be responsible for the Company's technology, including infrastructure, eCommerce platforms and new and evolving digital platforms. Gaffney joins DICK'S from The Home Depot, where he most recently served as the Senior Vice President of Information Technology, responsible for the organization's software engineering, user-centered design and applications. While at The Home Depot (HD), Gaffney was responsible for leading their digital revolution, inspiring the engineering team to deliver customer focused software to millions of customers and over 400,000 associates.

08:31 EDT New Age Beverages reports Q3 revenue $16.8M, consensus $18.45M

08:23 EDT Cheniere Energy sees FY18 adjusted EBITDA $1.9B-$2.1B - Sees FY18 distributable cash flow $200M-$400M

08:22 EDT Cheniere Energy revised FY17 adjusted EBITDA to $1.8B-$1.9B - Revised FY17 distributable cash flow to $600M-$700M

08:18 EDT Cheniere Energy Partners narrows FY17 distribution view to $1.73-$1.80 - Prior view was $1.70-$1.90.

08:14 EDT Cheniere Energy Partners LP sees FY18 dividend $2.05-$2.25

08:08 EDT E-Trade reports October DARTs up 28% y/y - E*TRADE Financial Corporation released its Monthly Activity Report for October 2017. Daily Average Revenue Trades for October were 215,689, a 7% increase from September and a 28% increase from the year-ago period. Derivatives represented 31% of DARTs during the month. The company added 37,636 gross new brokerage accounts in October and ended the month with approximately 3.6M brokerage accounts, which remained flat from September. Net new brokerage assets were $0.6B in the month. During the month, customer security holdings increased by $8.4B, and brokerage-related cash increased by $0.5B to $52.8B. Customer margin balances decreased $0.1B ending the month at $8.4B. Customers were net buyers of approximately $0.1B in securities during the month.

08:07 EDT CVS Health commits to hiring 5,000 new apprentices by 2022 - CVS Health announced it has set a goal of hiring 5,000 new apprentices by 2022. The newly established goal, which coincides with the U.S. Department of Labor's National Apprenticeship Week, reflects an expansion of the company's Registered Apprenticeship program to seven additional states, including Arizona, Hawaii, Illinois, Indiana, Iowa, Massachusetts and Pennsylvania, bringing the total number of statewide apprenticeship programs supported by CVS Health to 18.

08:04 EDT Alliance MMA partners with Nova Signa Business Development - Alliance MMA announced the formation of a promotional partnership with Nova Signa Business Development, a fully integrated consulting firm that specializes in sales, marketing and branding initiatives. "While Alliance MMA has continued to make positive strides in achieving our stated objective of producing at least 125 regional MMA events per year, which in turn facilitates attracting national brand sponsorships, it is equally critical that we capture significant sponsorship revenue at the local event level," said CEO Paul Danner."Towards that end, we recently redeployed Scott Viscomi as the company's Director, Event Sales & Marketing. In his new capacity, Scott is tasked with creating an independent national sales force, fortified with existing local merchant relationships, through which Alliance MMA expects to substantially increase our local event-related revenue. This vital new initiative was launched in September, and we expect to begin seeing results during the 4th quarter of this year." Beyond leading the company's independent sales force, Viscomi will also work closely with the Nova Signa team to explore additional event-centric sponsorship opportunities to bolster the Company's revenue and profitability. Steeped in the combat sports space, Nova Signa intends to identify and secure key incremental sponsorship relationships for the company's ten branded promotions across the country.

08:03 EDT Cheniere Energy revised FY17 adjusted EBITDA to $1.8B-$1.9B - Sees FY17 Distributable Cash Flow $600M-$700M.

07:40 EDT Pacira says FDA advisory committee to review sNDA for Exparel - Pacira Pharmaceuticals announced that the FDA) has notified the company that its supplemental New Drug Application, or sNDA, for Exparel as a nerve block for regional analgesia will be discussed at a meeting of the Anesthetic and Analgesic Drug Products Advisory Committee, or AADPAC. The meeting is tentatively scheduled for February 14-15, 2018. A definitive date for the advisory committee meeting is expected to be published by FDA in the Federal Register at least 15 days prior to such meeting. The Prescription Drug User Fee Act goal date for completion of review by FDA of April 6, 2018 remains unchanged.

07:38 EDT Dick's Sporting CEO: 'Well positioned to gain additional market share' in Q4 - "In the third quarter, we delivered earnings per diluted share and comp sales at the high end of our expectations, with continued double-digit growth in eCommerce. As expected, margins were under pressure in this highly promotional environment, but our strategy for this environment enabled us to continue to capture market share," said Edward Stack, Chairman and CEO. "As we look to the fourth quarter, we are comfortable with our prior implied sales and earnings outlook, and believe we are well positioned to gain additional market share."

07:35 EDT Dick's Sporting sees FY17 CapEx approximately $400M on a net basis - In 2017, the company anticipates capital expenditures to be approximately $400M on a net basis and approximately $515M on a gross basis. In 2016, capital expenditures were $242M on a net basis and $422M on a gross basis.

07:31 EDT USG to acquire Ceilings Plus for $52M - USG Corporation announced that it has entered into a definitive agreement to acquire Ceilings Plus, a leading manufacturer of specialty ceilings products. Upon closing, USG will pay approximately $52M in cash, on a cash-free and debt-free basis. The pending transaction, which is subject to customary closing conditions, is expected to close by the end of 2017. Ceilings Plus employs more than 150 people at two facilities in California and Georgia. Ceilings Plus is expected to generate 2017 sales in excess of $45M. Founder and president Nancy Mercolino will continue to lead the business and be based in Los Angeles.

07:30 EDT Loxo Oncology trading resumes

07:14 EDT Sierra Metals reports mineral estimates increased for Yauricocha Mine - Sierra Metals has filed a technical report prepared in accordance with National Instrument 43-101 on the Yauricocha Mine. The Report supports the disclosure made by the Company in its news releases dated September 28 entitled "Sierra Metals Significantly Increases Mineral Resource Estimate for Yauricocha Mine, Peru." and dated October 26 entitled "Sierra Metals Significantly Increases Mineral Reserve Estimate for Yauricocha Mine, Peru." The Report included: Total Proven and Probable Contained Metal has significantly increased by 86% silver, 237% copper, 58% lead, 96% zinc, and 97% gold as compared to the previous reserve estimate; Total Measured and Indicated Contained Metal has significantly increased by 72% silver, 128% copper, 74% zinc, 64% lead and 61% gold; Total Inferred Contained Metal has significantly increased by 55% silver, 59% copper, 105% zinc, 42% lead and 83% gold; Mineral Reserves for Yauricocha are 8,917,000 tonnes averaging 48.3 g/t silver, 1.2% copper, 0.8% lead, 2.4% zinc and 0.5 g/t gold representing a 135% tonnage increase compared to the previous Reserve Estimate; Mineral Resources for Yauricocha are 13,206,000 tonnes averaging 62.3 g/t silver, 1.5% copper, 0.9% lead, 2.8% zinc and 0.6 g/t gold representing a 68% tonnage increase from the previous resource estimate.

07:09 EDT Pratt & Whitney, EgyptAir: PurePower GTF selected to power Bombardier CS300 - Pratt & Whitney, a division of United Technologies Corp. (UTX), and EgyptAir announced the selection of the PurePower Geared Turbofan engine to power up to 24 Bombardier (BDRBF) CS300 aircraft. This includes 12 CS300s with purchase rights for an additional 12 aircraft. The order was announced during an event at the Dubai Airshow, which was attended by officials from EgyptAir, Bombardier and Pratt & Whitney. Deliveries are expected to begin in 2018.

07:06 EDT FactSet appoints Gene Fernandez as Chief Technology and Product Officer - FactSet (FDS) announced that Gene Fernandez will join FactSet as the Chief Technology and Product Officer, reporting directly to FactSet's CEO, Philip Snow. Fernandez joins FactSet from J.P. Morgan (JPM) where he was most recently the Chief Technology Officer, New Product Development. In the newly created Chief Technology and Product Officer role, Fernandez will oversee FactSet's Engineering, Product Development, and Quality Assurance functions.

07:05 EDT Loxo Oncology, Bayer enter into an exclusive global collaboration - Bayer (BAYRY) announced that the company has entered into an exclusive global collaboration with Loxo Oncology (LOXO) for the development and commercialization of larotrectinib (LOXO-101) and LOXO-195. Both compounds are being investigated in global studies for the treatment of patients with cancers harboring tropomyosin receptor kinase gene fusions, which are genetic alterations across a wide range of tumors resulting in uncontrolled TRK signaling and tumor growth. Under the terms of the agreement, Loxo Oncology will receive an upfront payment of $400M and is eligible for $450M in milestone payments upon larotrectinib regulatory approvals and first commercial sale events in certain major markets and an additional $200M in milestones payments upon LOXO-195 regulatory approvals and first commercial sale events in certain major markets. Bayer and Loxo Oncology will jointly develop the two products, larotrectinib and LOXO-195, and share development costs on a 50/50 basis. Bayer will lead ex-U.S. regulatory activities, and worldwide commercial activities. In the U.S., where Bayer and Loxo Oncology will co-promote the products, the parties will share commercial costs and profits on a 50/50 basis. Loxo Oncology will remain responsible for the filing in the U.S. Bayer will pay Loxo Oncology tiered double-digit percentage royalties on future net sales outside of the U.S., and U.S. and ex-U.S. sales milestones totaling $500M.

07:03 EDT YogaWorks acquires four premier studios in Atlanta - YogaWorks continues to expand its national footprint with the acquisition of Infinity Yoga's four Atlanta-based studios. This deal marks YogaWorks' entry into Georgia and expands the Company's portfolio to 66 locations across the country. YogaWorks remains dedicated to maintaining Infinity Yoga's programming and operations. Current teachers and staff will remain on board and Infinity Yoga's classes, workshops, teacher trainings and retreats will continue as scheduled.

06:55 EDT Loxo Oncology trading halted, news pending

06:47 EDT Descartes Systems's solution selected by Iceland Post - Descartes Systems Group and Iceland Post announced that Descartes' route planning solution is being deployed to manage delivery operations for Iceland Post as the company shifts its primary focus from mail to parcel delivery in support of the country's dramatic growth in ecommerce. Iceland Post is using Descartes' strategic route modelling capabilities to analyze territories, service levels and daily route planning processes to develop the most cost-effective delivery strategy.

06:34 EDT Chicken Soup for the Soul appoints Elana Sofko as COO - Chicken Soup for the Soul Entertainment announced that Elana Sofko has been appointed to the new position of COO. Sofko's qualifications include worldwide experience in distribution, monetization, digital tech and products, and business and corporate development. Sofko joined CSS Entertainment in 2016 as senior vice president of business development and distribution. Sofko brings over two decades of media and entertainment experience. Prior to joining the company, Sofko focused on a range of digital business growth initiatives for World Wrestling Entertainment, including international expansion and localization of WWE's digital properties. Sofko also supported the launch and international expansion of the WWE Network, a subscription-based video over-the-top service.

06:34 EDT Advance Auto Parts CEO: 'We remain on track to deliver our 2017 guidance' - "We continue to take steps to build the foundation for future growth. We executed key transformational initiatives, including a complete restructure of our field operations and professional sales leadership teams. This important step in our journey sets us up well for the future. In the third quarter, we delivered improvements in cost initiatives while positioning the business for future success. We remain on track to deliver our 2017 guidance," said Tom Greco, President and CEO.

06:32 EDT Advance Auto Parts backs FY17 new stores view of 60-65 - Backs FY17 CapEx view approximately $250M; FY17 free cash flow view minimum of $300M.

06:30 EDT Advance Auto Parts reports Q3 SSS down 3.4%

06:08 EDT Home Depot up 1.5% after reporting Q3 results, raising FY17 guidance

06:06 EDT SoftBank considering investment in Uber, no final deal has been reached - SoftBank said in a statement that "The Uber board and its shareholders, as well as the SoftBank Group side, have come to a basic agreement on a process for the SoftBank Group to make a future investment in Uber. However, while the SoftBank Group side is considering an investment in Uber, there is no final agreement at this stage. If conditions on share price and a minimum of shares are not satisfactory for the SoftBank Group side, there is a possibility the SoftBank Group may not make an investment."

06:06 EDT Seres Therapeutics, MD Anderson and Parker Institute announce collaboration - Seres Therapeutics, The University of Texas MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy announced a collaboration to evaluate the potential of Seres' microbiome therapies to improve the outcomes of cancer patients treated with currently-available immunotherapy. The collaborators plan to initiate a randomized, placebo-controlled clinical study at MD Anderson, sponsored by the Parker Institute, in patients with advanced metastatic melanoma. The clinical trial will evaluate the impact of an anti-PD-1 checkpoint inhibitor with adjunctive microbiome therapy on patient outcomes. Seres is developing SER-401, a preclinical stage oral microbiome therapy comprising a rationally-designed consortium of live bacteria, to improve the efficacy and safety of immunotherapy. Published studies provide preclinical and clinical evidence demonstrating that the composition of bacteria in the gastrointestinal microbiome may impact response to checkpoint inhibitor therapy.

06:03 EDT Apple retakes lead in werable band market in Q3, Canalys says - Apple (AAPL) retook the lead in the wearable band market in Q3 2017, with shipments of 3.9 million, Canalys says. It posted its strongest quarter so far in 2017, thanks to the release of the Apple Watch Series 3. Xiaomi and Fitbit (FIT), which shipped 3.6 million and 3.5 million wearable bands respectively, have also bucked the trend of the traditionally weaker Q3 by posting quarter-on-quarter growth. But despite the increase in smartwatch shipments, waning demand for basic bands meant the overall wearable band market fell 2% to reach 17.3 million units. "Strong demand for the LTE-enabled Apple Watch Series 3 has dispelled service providers' doubts about the cellular smartwatch not appealing to customers," said Canalys Analyst Jason Low. Despite strong shipments, the Apple Watch Series 3 did not reach its full potential in Q3. It suffered limited availability as demand outstripped supply in major markets. Service providers had underestimated demand for the new Apple Watch. According to Canalys estimates, 800,000 Apple Watch units shipped in Q3 were cellular-enabled. Samsung (SSNLF), Apple and Huawei, the top three smartphone vendors by volume in Q3 2017, have positioned smartwatches to complement their premium smartphones. "While health features continue to be the core focus, vendors are striving to increase the value of smartwatches by prioritizing design and highlighting key features," said Canalys Research Analyst Mo Jia. Vendors are expecting a stronger Q4 this year, with new smartwatches highlighting improved health-tracking features and longer battery life, on top of better and slimmer designs. Reference Link

05:54 EDT TSMC board approves capital injection of 'not more than' $2B to TSMC Global - TSMC held a meeting of the Board of Directors, which passed the following resolutions:1. Approved capital appropriations of approximately $4,284.5 million for purposes including: 1) $1,667.5 million for construction of fab facilities; 2) $2,617 million for other purposes including: Expanding and upgrading advanced technology capacity; Expanding advanced packaging technology capacity; Expanding specialty technology capacity; Conversion of logic capacity to specialty technology; First quarter 2018 R&D capital investments and sustaining capital expenditures.2. Approved the capital injection of not more than $2 billion to TSMC Global Ltd., a wholly-owned BVI subsidiary, for the purpose of reducing foreign exchange hedging costs.

05:48 EDT Amazon announces Black Friday deal preview - Amazon is offering a sneak peek of its plans for Black Friday and, with deals across 30 categories, there is something for everyone this holiday. Now through Black Friday, customers will find deals on items including toys, electronics, fashion, beauty, kitchen, sporting goods, and more, in addition to Amazon Devices and products from small businesses and entrepreneurs, at amazon.com/blackfriday. Customers can expect to find incredible deals across a wide selection of top holiday products throughout the duration of the "Turkey 5" - those five popular shopping days starting at midnight PT on Thanksgiving and continuing through Cyber Monday. Black Friday will feature more than 30 Deals of the Day and thousands of Lightning Deals. Customers will find new deals every day, all season long. Discover all of the great Amazon Black Friday deals at amazon.com/blackfriday or shop anytime, anywhere with the Amazon App. Customers shopping with the Amazon App can also set Watch a Deal alerts to ensure they never miss out on a hot holiday product, and even use AR view, a new augmented reality feature, to view thousands of items in their space before they buy. Voice Shoppers can shop select Black Friday deals, starting as early as 5pm PT, Wednesday, Nov. 22 - just ask Alexa. All Amazon customers can choose from more than one hundred million items that are eligible for free shipping this holiday and all year long. This includes eligible orders of $25 or more shipped by Amazon, as well as free shipping offers from small business and entrepreneurs selling on Amazon.

05:39 EDT Magic Software reports Q3 EPS 12c, consensus 15c - Reports Q3 revenue $65.7M, consensus $62.1M.

05:28 EDT MediWound ordered to purchase about $1.5M of PolyHeal shares by Tel Aviv Court - MediWound (MDWD) announced that the Tel Aviv District Court ordered that MediWound is obligated to purchases shares of three shareholders of PolyHeal for approximately $1.5M pursuant to a claim made by such PolyHeal shareholders. As previously disclosed, in 2010 MediWound entered into a series of agreements with Teva Pharmaceutical (TEVA) and PolyHeal to collaborate in the development, manufacturing and commercialization of PolyHeal's wound product. Under the 2010 series of agreements between PolyHeal and the company, PolyHeal granted us an exclusive global license to develop, manufacture and commercialize the PolyHeal Product, and the Company granted an exclusive worldwide sub-license to Teva to commercialize the PolyHeal Product. In addition, in accordance with the 2010 PolyHeal Agreements, Teva made investments in the Company's ordinary shares, agreed to fund MediWound's research and development expenses and certain manufacturing costs and perform all marketing activities for the PolyHeal Product under the 2010 PolyHeal Agreements. On November 15, 2012, the company informed Teva of the occurrence of a milestone under the 2010 PolyHeal Agreements, upon achievement of which, Teva was required to invest an additional $6.75M in exchange for the Company's ordinary shares. Following and pending such investment, the company was required to purchase, for an identical amount, ordinary shares of PolyHeal from its existing shareholders. The company has not received the milestone investment from Teva. The company believes that, under the terms of the 2010 PolyHeal Agreements, it was therefore under no obligation to purchase, and has not purchased, any additional shares of PolyHeal from its shareholders. On November 12, the Tel Aviv District Court issued its ruling accepting the plaintiffs' Claim. The Court ruled that the company is obligated to purchase PolyHeal's shares for approximately $6.75M, which represents the purchase price for the total number of shares that the buyout option agreement contemplates would be acquired by the company from the shareholders of PolyHeal. The Court ordered that the company is obligated to purchase shares in PolyHeal from the three PolyHeal shareholders that filed the Claim, on the basis of their actual share holdings in PolyHeal as of January 15, 2013, for approximately $1.5M, within 15 days from the date of the Court's ruling. The company continues to evaluate the ruling and its legal and accounting implications and the company's options, including a potential appeal.

05:20 EDT Sabra says transactions contemplated by Genesis Exodus MOU won't impact guidance - On November 8, Sabra Health Care REIT and Genesis Healthcare entered into a memorandum of understanding, or MOU, relating to the remaining 43 facilities leased to Genesis as detailed in the Current Report on Form 8-K filed by Sabra with the SEC on November 13. The company does not expect the transactions contemplated by the Genesis Exodus MOU to impact the company's previously issued full year guidance for 2017 or 2018.